Distinct roles but cooperative effect of TLR3/9 agonists and PD-1 blockade in converting the immunotolerant microenvironment of irreversible electroporation-ablated tumors
Fatma Babikr(University of Saskatchewan), Jim Xiang(University of Saskatchewan), Shahid Ahmed(Emory University), Mike Moser(Roswell Park Comprehensive Cancer Center), Rajni Chibbar(Royal University Hospital), Andrew Freywald(Royal University Hospital), Yue Wu(Mayo Clinic), Aizhang Xu(University of Saskatchewan), Bing Zhang(Xi'an Jiaotong University), Wenjun Zhang(Shanghai Jiao Tong University), Jiangbo Wan(Shanghai Jiao Tong University), Zhaojia Wu(University of Saskatchewan), Gary Groot(Royal University Hospital)
Cited by 42
Related Papers
Obesity and Cancer: A Current Overview of Epidemiology, Pathogenesis, Outcomes, and Management
|Cancers|2023|640
Respiratory mucosal immunity against SARS-CoV-2 after mRNA vaccination
|Science Immunology|2022|366
Gallbladder Cancer in the 21st Century
|Journal of Oncology|2015|301
The Genotype-Tissue Expression (GTEx) project
|Nature Genetics|2013|266
A decision framework for the analysis of green supply chain contracts: An evolutionary game approach
|Expert Systems with Applications|2011|246